Sage Journals: Discover world-class research

Open access

Review article

First published 2020

Optimal treatment strategy for metastatic melanoma patients harboring BRAF-V600 mutations

Emilio Francesco Giunta, Vincenzo De Falco, Stefania Napolitano [...]

Therapeutic Advances in Medical Oncology

Open access

Research article

First published 2023-12

Outcomes in patients with BRAF V600 –mutated melanoma and brain metastases at baseline treated with dabrafenib plus trametinib

Massimo Aglietta, Vanna Chiarion-Sileni, Paolo Fava [...]

Tumori Journal

Open access

Editorial

First published 2012-5

Metastatic Melanoma and Vemurafenib: Novel Approaches

Ramon Andrade De Mello

Rare Tumors

Open access

Case report

First published 2015-6

Amelanotic Melanoma Presenting with Plasmacytoid Morphology and BRAF V600 Mutation

Linda Kocovski, Anita Bane, Shangguo Tang [...]

Rare Tumors

Retricted access

Research article

First published 2021-1

Prevalence of class I–III BRAF mutations among 114,662 cancer patients in a large genomic database

Jeff Owsley, Matthew K Stein, Jason Porter [...]

Experimental Biology and Medicine

Open access

Brief report

First published 2021

Durable Progression-Free Survival With the Use of BRAF and MEK Inhibitors in Four Cases With BRAF V600E-Mutated Gliomas

Michael J. Fusco, Yolanda Piña, Robert J. Macaulay [...]

Cancer Control

Retricted access

Case report

First published 2017-6

Acute encephalopathy with combination dabrafenib/trametinib therapy

Jalyn Cooper, Dheeraj Kodali, Gerald M Higa

Journal of Oncology Pharmacy Practice

Retricted access

Research article

First published 2024-04

A Phase 2 Study of Encorafenib in Combination with Binimetinib in Patients with Metastatic BRAF -Mutated Thyroid Cancer in Japan

Makoto Tahara, Naomi Kiyota, Hiroo Imai [...]

Thyroid®

Free access

Research article

First published 2012-3

The potential for BRAF V600 inhibitors in advanced cutaneous melanoma: rationale and latest evidence

Charlotte Lemech, Jeffrey Infante, Hendrik-Tobias Arkenau

Therapeutic Advances in Medical Oncology

Retricted access

Research article

First published 2014-05

Prevalence,Tumorigenic Role,and Biochemical Implications of Rare BRAF Alterations

Susi Barollo, Raffaele Pezzani, Andrea Cristiani [...]

Thyroid®

Search results